Medical marijuana will be made available on prescription in the U.K., after it was approved for use by the British government, reports BBC News.

The decision comes after Billy Caldwell, a 12-year-old boy who suffers from a rare form of epilepsy, was granted an emergency license allowing him to be treated with medical marijuana by Northern Ireland’s Department of Health earlier this month.

Cannabis was previously listed as a Schedule 1 drug, meaning it was thought to have no therapeutic value but can be used for the purposes of research with a Home Office license, and with the new ruling, it has now been updated as a Schedule 2 drug, which means that it has a potential medical use.

Home secretary Sajid Javid, who made the decision said, "Recent cases involving sick children made it clear to me that our position on cannabis-related medicinal products was not satisfactory. Following advice from two sets of independent advisors, I have taken the decision to reschedule cannabis-derived medicinal products – meaning they will be available on prescription. This will help patients with an exceptional clinical need."

Javid added that the ruling was "in no way a first step to the legalisation of cannabis for recreational use."

Additionally, the United Kingdom's Department for Health and Social Care and the Medicines and Health products Regulatory Agency (MHRA), will now develop a clear definition of what constitutes a cannabis-derived medicinal product so they can be rescheduled and prescribed.

For the full story, head on over to BBC News, and for more, medical marijuana has no health risks and can help patients, WHO declares.

In related news, recreational marijuana use will soon be legal in Canada, and also, the New York Police Department will stop arresting New Yorkers for smoking weed in public.

What To Read Next

*If you submitted your e-mail address and placed an order, we may use your e-mail address to inform you regularly about similar products without prior explicit consent. You can object to the use of your e-mail address for this purpose at any time without incurring any costs other than the transmission costs according to the basic tariffs. Each newsletter contains an unsubscribe link. Alternatively, you can object to receiving the newsletter at any time by sending an e-mail to info@highsnobiety.com

Web Accessibility Statement

Titelmedia (Highsnobiety), is committed to facilitating and improving the accessibility and usability of its Website, www.highsnobiety.com. Titelmedia strives to ensure that its Website services and content are accessible to persons with disabilities including users of screen reader technology. To accomplish this, Titelmedia has engaged UsableNet Inc, a leading web accessibility consultant to help test, remediate and maintain our Website in-line with the Web Content Accessibility Guidelines (WCAG), which also bring the Website into conformance with the Americans with Disabilities Act of 1990.

Disclaimer

Please be aware that our efforts to maintain accessibility and usability are ongoing. While we strive to make the Website as accessible as possible some issues can be encountered by different assistive technology as the range of assistive technology is wide and varied.

Contact Us

If, at any time, you have specific questions or concerns about the accessibility of any particular webpage on this Website, please contact us at accessibility@highsnobiety.com, +49 (0)30 235 908 500. If you do encounter an accessibility issue, please be sure to specify the web page and nature of the issue in your email and/or phone call, and we will make all reasonable efforts to make that page or the information contained therein accessible for you.